Semax

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4–10), modified to enhance stability and biological activity. In research contexts, it has been studied primarily for potential nootropic, neuroprotective, and neurotrophic effects.

Preclinical studies suggest Semax may influence brain-derived neurotrophic factor (BDNF) expression, modulate dopaminergic and serotonergic pathways, and impact cognitive performance in experimental models. It has also been investigated in neurological research related to cerebral ischemia and stress adaptation.